Question 7859 — pharmacy and medications

Summary

Mr. Jean-Claude Raux alerts the Minister of Health and Prevention following the inquiry he himself received from a group of patients, their families and the AF3M association, concerning the decision taken by the High Authority for Health to de-reimburse innovative treatments implemented against multiple myeloma. This disease can take an aggressive form and defeat all treatment protocols. charge. These treatments, such as Car-T Cells or bispecific antibodies, constituted for these patients and their loved ones the only recourse to regain the hope of long months of remission and completely acceptable living conditions. A decision which, according to eminent specialists working in particular at the Nantes University Hospital and internationally recognized, marks the complete cessation of any possibility for new patients to enter the this protocol and therefore causes a loss of chance of survival for these patients. A decision that goes against the interests of science, research, patients and their loved ones. He wants to know his position on this subject.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.